Literature DB >> 22999258

The specific infectivity of hepatitis C virus changes through its life cycle.

Sun Ju Keum1, Sung Mi Park, Ji Hoon Park, Jong Ha Jung, Eun Ji Shin, Sung Key Jang.   

Abstract

Hepatitis C virus (HCV) causes liver diseases, such as hepatitis, liver cirrhosis, steatosis, and hepatocellular carcinoma. To understand the life cycle and pathogenesis of HCV, the one-step growth of HCV in a cell culture system was analyzed using a highly infectious variant of the JFH1 clone. The observed profiles of HCV RNA replication indicated that the synthesis of negative-strand RNAs occurred at 6 h (h) after infection, followed by the active synthesis of positive-strand RNAs. Our measurements of infectious virus production showed that the latent period of HCV was about 12 h. The specific infectivity of HCV particles (focus-forming unit per viral RNA molecule) secreted to the extracellular milieu early in infection was about 30-fold higher than that secreted later during infection. The buoyant densities of the infectious virion particles differed with the duration of infection, indicating changes in the compositions of the virion particles.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22999258     DOI: 10.1016/j.virol.2012.08.046

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  17 in total

1.  Advanced Hepatitis C Virus Replication PDE Models within a Realistic Intracellular Geometric Environment.

Authors:  Markus M Knodel; Paul Targett-Adams; Alfio Grillo; Eva Herrmann; Gabriel Wittum
Journal:  Int J Environ Res Public Health       Date:  2019-02-12       Impact factor: 3.390

2.  3D Spatially Resolved Models of the Intracellular Dynamics of the Hepatitis C Genome Replication Cycle.

Authors:  Markus M Knodel; Sebastian Reiter; Paul Targett-Adams; Alfio Grillo; Eva Herrmann; Gabriel Wittum
Journal:  Viruses       Date:  2017-09-30       Impact factor: 5.048

3.  Detergent-resistant membrane association of NS2 and E2 during hepatitis C virus replication.

Authors:  Saravanabalaji Shanmugam; Dhanaranjani Saravanabalaji; MinKyung Yi
Journal:  J Virol       Date:  2015-02-11       Impact factor: 5.103

4.  Life cycle process dependencies of positive-sense RNA viruses suggest strategies for inhibiting productive cellular infection.

Authors:  Harsh Chhajer; Vaseef A Rizvi; Rahul Roy
Journal:  J R Soc Interface       Date:  2021-11-10       Impact factor: 4.118

Review 5.  Interferon at the cellular, individual, and population level in hepatitis C virus infection: Its role in the interferon-free treatment era.

Authors:  Rubesh Raja; Subhasish Baral; Narendra M Dixit
Journal:  Immunol Rev       Date:  2018-09       Impact factor: 12.988

6.  Replication vesicles are load- and choke-points in the hepatitis C virus lifecycle.

Authors:  Marco Binder; Nurgazy Sulaimanov; Diana Clausznitzer; Manuel Schulze; Christian M Hüber; Simon M Lenz; Johannes P Schlöder; Martin Trippler; Ralf Bartenschlager; Volker Lohmann; Lars Kaderali
Journal:  PLoS Pathog       Date:  2013-08-22       Impact factor: 6.823

7.  Spatiotemporal analysis of hepatitis C virus infection.

Authors:  Ana Shulla; Glenn Randall
Journal:  PLoS Pathog       Date:  2015-03-30       Impact factor: 6.823

8.  Inferring viral dynamics in chronically HCV infected patients from the spatial distribution of infected hepatocytes.

Authors:  Frederik Graw; Ashwin Balagopal; Abraham J Kandathil; Stuart C Ray; David L Thomas; Ruy M Ribeiro; Alan S Perelson
Journal:  PLoS Comput Biol       Date:  2014-11-13       Impact factor: 4.475

9.  Mutual antagonism between circadian protein period 2 and hepatitis C virus replication in hepatocytes.

Authors:  Giorgia Benegiamo; Gianluigi Mazzoccoli; Francesco Cappello; Francesca Rappa; Nunzia Scibetta; Jude Oben; Azzura Greco; Roger Williams; Angelo Andriulli; Manlio Vinciguerra; Valerio Pazienza
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240

10.  The paradox of highly effective sofosbuvir-based combination therapy despite slow viral decline: can we still rely on viral kinetics?

Authors:  Thi Huyen Tram Nguyen; Jérémie Guedj; Susan L Uprichard; Anita Kohli; Shyam Kottilil; Alan S Perelson
Journal:  Sci Rep       Date:  2017-08-31       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.